2021 American Transplant Congress » Biomarkers, Immune Assessment and Clinical Outcomes - II

Date: Sunday, June 6, 2021

Time: 4:30pm-5:30pm

Location: Virtual

Session Type: Rapid Fire Oral Abstract

Meeting: 2021 American Transplant Congress

4:30pm-4:35pm: Development and Validation of a Novel Peripheral Blood Based Gene Signature for Acute Rejection Following Renal Transplantation

D. Zhang, Y. Wang, X. Hu

4:35pm-4:40pm: Multiplexed Imaging Mass Cytometry of the Alloimmune Landscape of Rejection in Clinical Liver Transplantation

J. Emamaullee, N. Ung, C. Man, J. Hoeflich, C. Goldbeck, A. Barbetta, R. Sun, N. Matasci, J. Katz, J. Lee, S. Chopra, L. Sher, S. Asgharzadeh, O. Akbari, Y. Genyk

4:40pm-4:45pm: Hypothermic Oxygenated Machine Perfusion Protects Against Cholangiocyte and Hepatocyte Injury and Mitigates Inflammation vs Static Cold Storage: Preliminary Results from a Single Center

G. Panayotova, F. Paterno, M. McCarty, G. Dikdan, S. Simonishvili, Y. Qin, L. Brown, A. Amin, K. E. Lunsford, J. V. Guarrera

4:45pm-4:50pm: The Effect of the Affordable Care Act on Insurance Status, Waitlist, and Transplant Outcomes in Liver Transplantation

B. I. Shaw¹, M. L. Samoylova¹, V. Wang², T. Risoli Jr³, S. Peskoe³, K. Caddell³, L. M. McElroy¹

4:50pm-4:55pm: Gain of Function Mutations in Latent Membrane Protein 1 of Epstein Barr Virus are Associated with Increased Risk of Post-Transplant Lymphoproliferative Disorder

O. M. Martinez¹, S. M. Krams¹, M. Robien², M. Lapasaran¹, M. Arvedson¹, K. Weinberg¹, S. Boyd¹, B. Armstrong³, C. Twist⁴, D. Gratzinger¹, B. Tan¹, A. Trickey¹, M. Sever³, M. Brown², D. Bernstein¹, C. O. Esquivel¹

4:55pm-5:00pm: Clinical and Molecular Profiling Can Help in Predicting the Response to Alemtuzumab Treatment in Kidney Transplant Recipients with Severe or Glucocorticoid-Resistant Acute Rejection

D. M. Peelen¹, M. van der Zwan¹, M. C. Clahsen-van Groningen², D. A. Mustafa², C. C. Baan¹, D. A. Hesselink¹

5:00pm-5:05pm: Identification of Distinct Blood Monocyte Phenotypes from Transplant Kidney Recipients Undergoing Cellular (TCMR) and Mixed Antibody Mediated Rejection (ABMR)

C. Macedo, E. Bailly, K. Louis, M. Lucas, A. Zeevi, P. Randhawa, D. Metes

5:05pm-5:10pm: Validation of a Novel Gene Expression Biomarker of Rejection Following Liver Transplantation

J. Levitsky¹, M. Kandpal¹, T. Whisenant², K. Guo¹, S. Kurian³, M. Abecassis⁴

« View all sessions from the 2021 American Transplant Congress